SLC2A1 and non-small cell lung carcinoma: In addition, DHA also has been shown to inhibit the development of non-small cell lung cancer metastasis by inhibiting the NF-κB/GLUT1 axis (Jiang et al., 2016) and has been demonstrated to enhance the anti-pancreatic cancer potential of gemcitabine via inhibition of the NF-κB axis (Wang et al., 2010).